Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
NOVO HOLDINGS A/S AVLN Avalyn Pharma Inc. 13G 8.8% 3mo
American Century Investment Management, Inc. OMDA Omada Health, Inc. 13G 6.2% 3mo
American Century Investment Management, Inc. SKYW Skywest Inc 13G 5.7% 3mo
D. E. Shaw & Co., L.P. WNC WABASH NATIONAL Corp 13G/A 5.1% 3mo
American Century Investment Management, Inc. YSWY Yesway, Inc. 13G 6.2% 3mo
G1 Execution Services, LLC WYNN Wynn Resorts Ltd 13G/A 4.1% 3mo
Avoro Capital Advisors LLC COAG Hemab Therapeutics Holdings, Inc. 13G 7.06% 3mo
ARIEL INVESTMENTS, LLC MSGE Madison Square Garden Entertainment Corp. 13G/A 13.1% 3mo
CITADEL ADVISORS LLC FGC FG Communities Holdings Inc. 13G/A 4.2% 3mo
METEORA CAPITAL, LLC DNMX Dynamix Corp III 13G/A 9.28% 3mo
Cormorant Asset Management, LP CABA Cabaletta Bio, Inc. 13G/A 5.95% 3mo
Rubric Capital Management LP AVO Mission Produce, Inc. 13G 6.77% 3mo
Nantahala Capital Management, LLC KPRX Kiora Pharmaceuticals Inc 13G/A 9.99% 3mo
CADIAN CAPITAL MANAGEMENT, LP FLYW Flywire Corp 13G/A 4.7% 3mo
VAN ECK ASSOCIATES CORP CDE Coeur Mining, Inc. 13G/A 6.5% 3mo
Orbis Investment Management Limited MCS Marcus Corp 13G/A 9.1% 3mo
Select Equity Group, L.P. SIG Signet Jewelers Ltd 13G/A 6.2% 3mo
PERCEPTIVE ADVISORS LLC TENX Tenax Therapeutics, Inc. 13G/A 4.5% 3mo
Linden Advisors LP TONT Graf Global Corp. 13G/A 0% 3mo
Schonfeld Strategic Advisors LLC INBX Inhibrx Biosciences, Inc. 13G 5.33% 3mo
Caracola Ventures Corp NUAI New ERA Energy & Digital, Inc. 13G/A 8.9% 3mo
ARMISTICE CAPITAL, LLC INBS Intelligent Bio Solutions Inc. 13G/A 5.91% 3mo
METEORA CAPITAL, LLC BDCI BTC Development Corp. 13G/A 7.52% 3mo
Jericho Capital Asset Management L.P. CORZ Core Scientific, Inc. 13G 7.2% 3mo
Sirenia Capital Management LP QTTB Q32 Bio Inc. 13G/A 0% 3mo
First Trust Capital Management L.P. DMAA Drugs Made In America Acquisition Corp. 13G/A 3.24% 3mo
Karpus Management, Inc. OXLC Oxford Lane Capital Corp. 13G/A 4.3% 3mo
ARMISTICE CAPITAL, LLC TNON Tenon Medical, Inc. 13G 9.99% 3mo
Alyeska Investment Group, L.P. FAC Factorial Energy Inc. 13G 8.05% 3mo
Nantahala Capital Management, LLC RLYB Rallybio Corp 13G/A 3.56% 3mo
1607 Capital Partners, LLC JHI John Hancock Investors Trust 13G/A 4.01% 3mo
MMCAP International Inc. SPC IPFX Inflection Point Acquisition Corp. VI 13G/A 7.6% 3mo
ARISTEIA CAPITAL, L.L.C. IPFX Inflection Point Acquisition Corp. VI 13G 5.2% 3mo
First Light Asset Management, LLC NEO Neogenomics Inc 13G/A 8.37% 3mo
Nantahala Capital Management, LLC IRLA IRulya Therapeutics Inc. 13G/A 0% 3mo
ADAR1 Capital Management, LLC KRSA Korsana Biosciences, Inc. 13G 7% 3mo
BCLS I Investco, LP RPID Rapid Micro Biosystems, Inc. 13G/A 16.76% 3mo
Paradigm Biocapital Advisors LP ASMB Assembly Biosciences, Inc. 13G/A 7.8% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ DGX Quest Diagnostics Inc 13G/A 4.9% 3mo
1607 Capital Partners, LLC MIN Aberdeen Intermediate Income Fund 13G/A 3.91% 3mo
QP Vive Aggregator, LLC SUJA Suja Life, Inc. 13G 5.7% 3mo
CITADEL ADVISORS LLC GLND Greenland Energy Co 13G/A 5.8% 3mo
ALLIANCEBERNSTEIN L.P. TYFG Tri-County Financial Group, Inc. 13G 9.1% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ EVMN Evommune, Inc. 13G 5.4% 3mo
AMERIPRISE FINANCIAL INC TRIP TripAdvisor, Inc. 13G/A 9.1% 3mo
Yield Point NY LLC KUST Kustom Entertainment, Inc. 13G/A 1.4% 3mo
ARISTEIA CAPITAL, L.L.C. DRDB Roman DBDR Acquisition Corp. II 13G/A 4.5% 3mo
3i, LP CNBX CNBX Pharmaceuticals Inc. 13G/A 9.9% 3mo
D. E. Shaw & Co., L.P. RDAC Rising Dragon Acquisition Corp. 13G 8% 3mo
ALLIANCEBERNSTEIN L.P. OI O-I Glass, Inc. 13G/A 6.3% 3mo